GENE ONLINE|News &
Opinion
Blog

COVID-19
Pfizer Pledges 6 million COVID-19 Treatment Courses to Global Fund
2022-09-22
The COVID-19 Pandemic: Is Omicron the Last Variant?
2022-09-16
WHO Urges Action After Model Suggests Over 17 Million Europeans Experienced Long COVID
2022-09-14
U.S. Government to No Longer Provide Free COVID-19 Vaccines
2022-08-31
FDA Approves Both Moderna’s and Pfizer/BioNTech’s Omicron Bivalent Vaccines in One Day
2022-08-31
AstraZeneca’s Role in COVID-19 Slows Down as World Looks to mRNA Vaccines
2022-08-31
Moderna Wins the First Regulatory Approval for an Omicron Bivalent Vaccine
2022-08-30
Moderna’s Lawsuit Against Pfizer/BioNTech: What Does This Mean for Their Vaccine’s future?
2022-08-26
FDA Removes N95 Respirators From the Medical Device Shortage List
2022-08-26
Moderna Follows Pfizer With Their Own Omicron BA.4/BA.5 Application to the FDA
2022-08-24
Pfizer-BioNTech COVID-19 Vaccine Proven Effective in Young Children
2022-08-23
Pfizer and BioNTech’s New Bivalent Omicron Vaccine Lined Up for Authorization from the FDA
2022-08-22
EMA Begins Review of SK biosciences’ New Non-mRNA COVID-19 vaccine
2022-08-18
Despite Global Acceptance, The UK Refuses to Buy AstraZeneca’s Evusheld, Citing ‘Insufficient Data’
2022-08-16
Antibody Treatment for Multiple Varieties of CoronaVirus
2022-08-16
1 2 3 24
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!